Exagen Inc. XGN Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s common stock shares outstanding?
- Exagen Inc. (XGN) reported common stock shares outstanding of $186K in Q1 2026.
- How has Exagen Inc.'s common stock shares outstanding changed year-over-year?
- Exagen Inc.'s common stock shares outstanding decreased by 34.0% year-over-year, from $282K to $186K.
- What is the long-term trend for Exagen Inc.'s common stock shares outstanding?
- Over 5 years (2020 to 2025), Exagen Inc.'s common stock shares outstanding has grown at a -32.3% compound annual growth rate (CAGR), from $6.75M to $957K.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.